Fulgent Genetics, Inc. (FLGT) NASDAQ
15.96
+0.16(+1.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
15.96
+0.16(+1.01%)
Currency In USD
| Market Cap | 808.51M |
| Enterprise Value | 766M |
| P/E Ratio | -6.68 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 1.41 |
| Price/Book Ratio | 0.47 |
| Enterprise/Revenue | 1.37 |
| Enterprise/EBITDA | -6.55 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.23 |
| Operating Margin | -0.33 |
| Return On Assets | -0.06 |
| Return On Equity | -0.07 |
| Revenue | 322.67M |
| Revenue/Share | 10.37 |
| Gross Profit | 130.88M |
| EBITDA | -45.83M |
| Net Income | -60.51M |
| Diluted EPS | -1.97 |
| Total Cash | 276.3M |
| Total Cash/Share | 8.95 |
| Total Debt | 10.17M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.31 |
| Book Value Per Share | 33.81 |
| 52-Week Change | -21.34 |
| 52-Week High | 31.04 |
| 52-Week Low | 13.46 |
| Moving Average 50 Days | 15.47 |
| Moving Average 200 Days | 22.08 |
| Average Volume | 655,781 |
| Shares Outstanding | 28.4M |
| % Held by Institutions | 58.06 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |